Results 51 to 60 of about 1,744 (184)
Treatment of gram - positive infections in critically ill patients [PDF]
Gram-positive bacteria to include methicillin-resistant Staphylococcus aureus (MRSA), methicillin-susceptible Staphylococcus aureus (MSSA), and enterococci, to include vancomycin-resistant enterococci (VRE), display a remarkable array of resistance and ...
Cristina Vazquez-Guillamet +1 more
core +2 more sources
Summary Background and objectives Erysipelas, caused by beta‐hemolytic streptococci, and limited cellulitis, frequently caused by Staphylococcus aureus or other bacteria, are skin and soft tissue infections characterized by typical clinical signs. However, despite the therapeutical relevance they are often not differentiated (e.g in clinical trials ...
Christian Drerup +3 more
wiley +1 more source
Complicated infections such as osteomyelitis, skin and soft tissue infections or endocarditis often require antibiotic therapies that can last up to several weeks. The prolonged hospital length of stay (LOS) leads to a dramatic increase in costs.
Wilke, Michael +5 more
doaj +1 more source
Zusammenfassung Hintergrund und Ziele Das Erysipel, hervorgerufen durch beta‐hämolysierende Streptokokken, und die begrenzte Phlegmone, häufig ausgelöst durch Staphylococcus aureus oder andere Bakterien, sind Infektionen der Haut und des Weichteilgewebes mit typischen klinischen Symptomen. Allerdings wird oft (etwa in klinischen Studien) nicht zwischen
Christian Drerup +3 more
wiley +1 more source
BackgroundOritavancin is a lipoglycopeptide antibiotic with in vitro bactericidal activity against gram-positive pathogens indicated for use in adults with acute bacterial skin and skin structure infections (ABSSSI).
Kimberly Saddler +8 more
doaj +1 more source
Background: Early and effective treatment of patients with sepsis requires early recognition in emergency department and understanding the severity of the disease. Many studies have been conducted for this purpose, and many of scoring systems have been developed that provide early recognition of these patients and show their severity.
Maruf Beğenen +3 more
wiley +1 more source
Use of Oritavancin in Moderate-to-Severe ABSSSI Patients Requiring IV Antibiotics: A U.S. Payer Budget Impact Analysis [PDF]
It is estimated that acute bacterial skin and skin structure infections (ABSSSI) account for nearly 10% of hospital admissions and 3.4-3.8 million emergency department visits per year in the United States. Analyses of hospital discharge records indicate 74% of ABSSSI admissions involve empiric treatment with methicillin-resistant Staphylococcus aureus (
Ivar S, Jensen +7 more
openaire +2 more sources
Objectives: Delafloxacin is a broad-spectrum anionic fluoroquinolone with activity against Gram-positive and Gram-negative organisms, including methicillin-resistant Staphylococcus aureus.
Dee Shortridge +3 more
doaj +1 more source
456. Dalbavancin, a Long-Acting Lipoglycopeptide Antimicrobial Agent, Reduces Length of Stay and Improves Patient Work Productivity in a Hospital Critical Pathway for Acute Bacterial Skin and Skin Structure Infections (ABSSSI)—the ENHANCE ABSSSI Trial [PDF]
Abstract Background Prolonged admissions for acute bacterial skin and skin structure infections (ABSSSI) present an opportunity to improve efficiency and quality of care. A primary reason for admission for ABSSSI is to receive intravenous (IV) antibiotics, where multiple guidelines support shifting ...
McCarthy, Matthew W +5 more
openaire +1 more source
Background: The treatment of acute bacterial skin and skin structure infections (ABSSSI) usually involves intravenous (i.v.) antibiotics requiring hospitalisation and increasing hospital costs.
Christoph T. Baltin +10 more
doaj +1 more source

